Sorbitol & Sorbitol Excipient Use in Tablet Orally Disintegrating Delayed Release Dosage Forms

Sorbitol

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

31 Listed Products, 24 Roquette, 2 SPI Pharma, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Zhejiang Huakang Pharmaceutical, 1 Nanjing Well Pharmaceutical, 1 Gangwal Healthcare, 1 Rochem International Inc

REGULATORY FILINGS

9 Suppliers, 2 USDMF, 2 CEP/COS, 1 NDC API, 6 Listed Suppliers

SOLUTIONS BY APPLICATIONS

17 Fillers, Diluents & Binders, 9 Film Formers & Plasticizers, 8 Taste Masking, 4 Coating Systems & Additives, 2 Parenteral, 2 Chewable & Orodispersible Aids, 1 Direct Compression, 1 Co-Processed Excipients, 1 Soft Gelatin

REF. STANDARDS & IMPURITIES

1 Others

1 Others

FINISHED FORMULATIONS

279 ORAL, 81 SOLUTION, 50 CAPSULE, 39 SYRUP, 34 TABLET, 33 INJECTABLE, 31 SUSPENSION, 30 TOPICAL, 25 INJECTION, 22 CREAM, 21 FOR SUSPENSION, 18 BUCCAL, 18 GUM, CHEWING, 9 INTRAVENOUS, 9 TABLET, ORALLY DISINTEGRATING, 6 OPHTHALMIC, 6 SOLUTION/DROPS, 5 TABLET, EXTENDED RELEASE, 4 CREAM, AUGMENTED, 4 ELIXIR, 4 NASAL, 4 SPRAY, METERED, 3 PATCH, 3 POWDER, 3 SUBCUTANEOUS, 2 CONCENTRATE, 2 OINTMENT, 2 SUSPENSION/DROPS, 2 TABLET, CHEWABLE, 2 VAGINAL, 1 DENTAL, 1 FOR SOLUTION, 1 INTRAVENOUS, SUBCUTANEOUS, 1 ORAL, RECTAL, 1 PASTE, 1 SUBLINGUAL, 1 SUSPENSION, EXTENDED RELEASE, 1 SYSTEM, 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE